Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Clove leaf extract lowers bad cholesterol and increases good cholesterol while also increasing body weight.

USPlus PRO saw palmetto extract improves urinary symptoms and is safe for men.

Finasteride overdose can cause acute pancreatitis.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

Saw palmetto is not proven to improve urinary flow, prostate size, or hair loss.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

High doses of finasteride lower cholesterol and body weight in certain mice.

Hair loss at the top of the head is linked to prostate cancer, but other types of hair loss are not.

% free PSA and urinary markers help better identify prostate cancer.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride reduces prostate size and PSA levels in young men with hair loss.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Early hair loss may indicate prostate issues.

Finasteride affects prostate weights and pituitary activity differently with age.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.